Rat embryo cell cultures were synchronized by a double thymidine block. The DNA replication phase (S) was divided into an early, middle, and late period. Cell cultures in the early, middle, or late S phase were pulsed with 0.1 JM 5-bromo[3H]deoxyuridine (BrdU) or equimolar [3HldT. DNA The thymidine analog 5-bromodeoxyuridine (BrdU) induces the synthesis of a latent type C virus in secondary cultures of normal rat embryo cells (1) . Release of type C particles into the culture fluids was first detected 2 days after BrdU removal, peaked 8-10 days later, and disappeared 14-16 days after removal of the analog. Density gradient centrifugation and DNA -DNA reassociation experiments revealed extensive and uniform base substitutions throughout the DNA sequences of rat embryo cells at the optimal virogenic BrdU dose (0.1 mM) (2). However, [3H] (2, 3) . The specific activity of each DNA sample was determined. Aliquots of radiolabeled DNA were centrifuged to equilibrium in gradients of neutral CsCl (2, 3). Gradient fractions were assayed for radioactivity, absorbance, and refractive index as described (2, 3).
The thymidine analog 5-bromodeoxyuridine (BrdU) induces the synthesis of a latent type C virus in secondary cultures of normal rat embryo cells (1) . Release of type C particles into the culture fluids was first detected 2 days after BrdU removal, peaked [8] [9] [10] days later, and disappeared 14-16 days after removal of the analog. Density gradient centrifugation and DNA -DNA reassociation experiments revealed extensive and uniform base substitutions throughout the DNA sequences of rat embryo cells at the optimal virogenic BrdU dose (0.1 mM) (2) . However, [3H]BrdU was incorporated predominantly into the repetitive and intermediate repetitive DNA sequences when the concentration of the analog was reduced to 0.1 pAM (2, 3) .
The questions arose whether viral functions are expressed at such low doses of BrdU and, if so, whether their expression is correlated with certain phases of the cell cycle. The present work shows that the 30,000 molecular weight group-specific antigen (p30) of Friend mouse leukemia virus is expressed in synchronized rat embryo cell cultures, treated with 0.1 IAM BrdU. Treatment with BrdU during the late portion of the synthetic (S) phase is sufficient for the expression of the p30 antigen. Moreover, [3H] BrdU is preferentially incorporated into the intermediate repetitive DNA of rat embryo cell cultures during S phase.
MATERIALS AND METHODS
Tissue Culture. Secondary cultures of 16-day old Wistar/ Furth (W/Fu) rat embryo cells were maintained as described (1) (2) (3) (4) (5) (6) . Subconfluent roller cultures were treated with 2 mM dT (Calbiochem). The dT-rich medium was replaced 16 hr later with 10,MM dG, dA, and dC for 8 hr (5, 6). Cells were rinsed and 2 mM dT was added for an additional 16 hr. Cultures were again rinsed and released into synchrony with 10,MM dG, dA, and dC as before (5, 6 (2, 3) . The specific activity of each DNA sample was determined. Aliquots of radiolabeled DNA were centrifuged to equilibrium in gradients of neutral CsCl (2, 3) . Gradient fractions were assayed for radioactivity, absorbance, and refractive index as described (2, 3) .
Renaturation Kinetics. Each DNA sample was made 0.40 M in sodium phosphate buffer, pH 6.8, and 3 mM in EDTA (2, 3, 7, 8 (2, 3, 7, 8) .
Detection of Viral Antigen. Cell cultures were grown on glass coverslips and synchronized. Following release from the thymidine block, representative samples were treated with 0.1 MM unlabeled BrdU (Sigma) for the entire S phase, the last 2/3 of the S phase, or the last 1/3 of the S phase. At the completion of the S phase, BrdU was removed and replaced immediately with 2 mM dT to prevent another round of DNA replication. Thereafter, coverslips were periodically withdrawn and fixed, and cells were examined by indirect cytoplasmic immunofluorescence (1, 5, 6) . Rabbit antisera to purified (30,000 molecular weight) interspecies-specific antigen of Friend mouse leukemia virus and pre-immune rabbit sera were generously supplied by Dr. D. Bolognesi, Duke University. The monospecificity of the immune serum has heen established (9) . The sera were diluted 1:50 or 1:100 with phosphate-buffered saline, pH 7 (Fig. 1) . The sharp peaks of [3H]dT incorporation and mitotic indices shown in Fig. 1 (9) . Furthermore, if the <7% substitution of thymine by bromouracil was sufficient to activate an endogenous type C virus, it was of interest to localize the critical site(s) in rat embryo DNA responsible for this effect.
Synchronized cells were treated with 0.1 uiM BrdU for periods shown in Table 2 . At the completion of the first S Proc. Nat. Acad. Sci. USA 72 (1975) phase, 2 mM dT was placed in the culture fluids to prevent further incorporation of retained BrdU. Table 2 shows that fluorescence was not detected in untreated, synchronized cells (Group I). Strong immunofluorescence appeared 12 hr after BrdU was removed from cells pulsed throughout the S phase (Group II). p30 antigen was also expressed in cells pulsed during the combined middle and late portions of the S phase (Group III). However, p30 antigen expression was variable in cells treated with BrdU during the late S phase (Group IV), as the monospecific antiserum reacted strongly positive in only two of four tests. We interpret this finding to imply that BrdU substitution responsible for virus antigen expression occurs in DNA sequences that replicate at the interface between the middle and late S phase (5-6 hr) portions. Equally strong cytoplasmic immunofluorescence appeared in cells 12 hr after exposure to 0.1 mM BrdU (Table 2) . DISCUSSION Although it has been shown repeatedly that information for endogenous type C virus is present in normal rat cells (1, 12, 13) , the mechanism(s) by which BrdU elicits virus synthesis is unclear. At optimal virogenic BrdU concentrations (0.1 mM), [3H] BrdU is incorporated uniformly into nuclear DNA sequences (2, 3, 14) , whereas [3H]BrdU at suboptimal concentrations (0.1 ,uM) is nonrandomly distributed as determined by DNA-DNA reassociation techniques (2, 3) . We now demonstrate that in synchronized rat embryo cells 0.1 ,uM BrdU is also incorporated nonrandomly during S phase. Furthermore, substitution into late replicating DNA sequences is sufficient for detection of subsequent p30 antigen expression.
The effective dose range for BrdU is broad for a number of experimental biological systems (15) . For example, BrdU effects were observed when nearly all thymine moieties of melanoma cell DNA were replaced (16) or when less than 2% of thymine was replaced by BrdU in avian limb bud mesenchyme (17) . Since the effective dose spans several orders of magnitude, it seems reasonable to assume that only a few critical regions of DNA need be substituted for most BrdU effects to occur. Moreover, the majority of substituted sequences are probably non-contributory to the highly specific suppression or activation of specialized cell functions characteristic of BrdU treatment (15) . Indeed, it has been suggested that selective incorporation into a few key regulatory elements may account for BrdU specificity (14, 15, 17, 18 
